Directly acting antivirals are safe and effective in HCV positive patients aged 80 years and older: a multicenter real-life study-Reference-Cited by-同舟云学术

Directly acting antivirals are safe and effective in HCV positive patients aged 80 years and older: a multicenter real-life study

Published:2021-05-12 Issue:7 Volume:20 Page:839-843
ISSN:1474-0338
Container-title:Expert Opinion on Drug Safety
language:en
Short-container-title:Expert Opinion on Drug Safety

Author:

Pugliese Nicola¹²^ORCID,Giorgini Alessia³,Maggi Daniela⁴,Capogreco Antonio²,Dibenedetto Clara³,Lubrano Lobianco Federica⁴,Dal Buono Arianna²^ORCID,Monico Sara³,Meli Rossella¹,Battezzati Pier Maria³,Lleo Ana¹²,De Santis Adriano⁴,Zuin Massimo³,Aghemo Alessio¹²

Affiliation:

1. Division of Internal Medicine and Hepatology, Department of Gastroenterology, Humanitas Research Hospital IRCCS, Rozzano, Milan, Italy

2. Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Milan, Italy

3. Liver and Gastroenterology Unit, Department of Health Sciences, Universita' degli Studi di Milano, DeparmtASST Santi Paolo E Carlo, University Hospital San Paolo, Milan, Italy

4. Department of Translational and Precision Medicine, Sapienza University, Rome, Italy

Publisher

Informa UK Limited

Subject

Pharmacology (medical),General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/14740338.2021.1921144

Reference18 articles.

1. Chronic Hepatitis C Virus Infection in the United States, National Health and Nutrition Examination Survey 2003 to 2010

2. Changing Trends in Hepatitis C Infection over the Past 50 Years in Japan

3. Characteristics of patients with hepatitis C virus-related chronic liver diseases just before the era of oral direct-acting antiviral therapy in Italy

4. Epidemiology and outcomes of hepatitis C infection in elderly US Veterans

5. Hepatitis C Infection in the Elderly

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Trends in Mortality Related to Hepatitis B and C from 1990 to 2019 in the Western Pacific Region;Gut and Liver;2024-04-19

2. Hepatitis C Virus Infection in the Elderly in the Era of Direct-Acting Antivirals: Evidence from Clinical Trials and Real Life;Tropical Medicine and Infectious Disease;2023-11-18

3. Glecaprevir/Pibrentasvir is safe and effective in Italian patients with chronic hepatitis C aged 75 years or older: A multicentre study;Liver International;2023-04-30

4. Hepatitis B and C mortality from 1990 to 2019 in China: a Bayesian age-period-cohort analysis;Annals of Translational Medicine;2022-12

5. Elbasvir/grazoprevir;Reactions Weekly;2021-10